Cargando…

New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada

IMPORTANCE: Opioids can impair motor skills and may affect the ability to drive; however, the association of opioid use with driving ability is not well established. OBJECTIVE: To examine the risk of motor vehicle collisions (MVCs) among drivers starting opioid therapy compared with that among drive...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Qi, McCormack, Daniel, Juurlink, David N., Bronskill, Susan E., Wunsch, Hannah, Gomes, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586904/
https://www.ncbi.nlm.nih.gov/pubmed/34762109
http://dx.doi.org/10.1001/jamanetworkopen.2021.34248
_version_ 1784597976428052480
author Guan, Qi
McCormack, Daniel
Juurlink, David N.
Bronskill, Susan E.
Wunsch, Hannah
Gomes, Tara
author_facet Guan, Qi
McCormack, Daniel
Juurlink, David N.
Bronskill, Susan E.
Wunsch, Hannah
Gomes, Tara
author_sort Guan, Qi
collection PubMed
description IMPORTANCE: Opioids can impair motor skills and may affect the ability to drive; however, the association of opioid use with driving ability is not well established. OBJECTIVE: To examine the risk of motor vehicle collisions (MVCs) among drivers starting opioid therapy compared with that among drivers starting nonsteroidal anti-inflammatory drug (NSAID) therapy. DESIGN, SETTING, AND PARTICIPANTS: This population-based, retrospective cohort study included all residents of Ontario aged 17 years or older who started new prescription analgesic therapy between March 1, 2008, and March 17, 2019. EXPOSURES: Initiation of opioid therapy or NSAID therapy, ascertained through prescription dispensing records in administrative data. MAIN OUTCOMES AND MEASURES: The primary outcome was an emergency department visit for injuries sustained as a driver in an MVC during the 14 days after starting analgesic therapy. Inverse probability treatment weighting was used to balance baseline covariates, and weighted Cox proportional hazards regression models were used to assess the association between new analgesic therapy and hazard of an emergency department visit after an MVC. RESULTS: Of the 1 454 824 individuals included in the study, 765 464 (52.6%) were new opioid recipients and 689 360 (47.4%) were new NSAID recipients. Most participants were aged 65 years or older (75.2%), and 55.2% were women. Of 194 individuals who had emergency department visits for injuries from an MVC within 14 days of initiating therapy, 98 (50.5%) were opioid recipients (3.41 per 1000 person-years; 95% CI, 2.80-4.15 per 1000 person-years) and 96 (49.5%) were NSAID recipients (3.64 per 1000 person-years; 95% CI, 2.98-4.45 per 1000 person-years). There was no significant difference in the risk of an emergency department visit for MVC injuries between opioid and NSAID recipients (weighted hazard ratio, 0.94; 95% CI, 0.70-1.25). CONCLUSIONS AND RELEVANCE: The findings of this study suggest that the hazard of an emergency department visit for injuries relating to an MVC as a driver is similar between individuals starting prescription opioids and those starting prescription NSAIDs. These results may be useful for patients, clinicians, and caregivers when considering new analgesic therapy.
format Online
Article
Text
id pubmed-8586904
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-85869042021-11-23 New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada Guan, Qi McCormack, Daniel Juurlink, David N. Bronskill, Susan E. Wunsch, Hannah Gomes, Tara JAMA Netw Open Original Investigation IMPORTANCE: Opioids can impair motor skills and may affect the ability to drive; however, the association of opioid use with driving ability is not well established. OBJECTIVE: To examine the risk of motor vehicle collisions (MVCs) among drivers starting opioid therapy compared with that among drivers starting nonsteroidal anti-inflammatory drug (NSAID) therapy. DESIGN, SETTING, AND PARTICIPANTS: This population-based, retrospective cohort study included all residents of Ontario aged 17 years or older who started new prescription analgesic therapy between March 1, 2008, and March 17, 2019. EXPOSURES: Initiation of opioid therapy or NSAID therapy, ascertained through prescription dispensing records in administrative data. MAIN OUTCOMES AND MEASURES: The primary outcome was an emergency department visit for injuries sustained as a driver in an MVC during the 14 days after starting analgesic therapy. Inverse probability treatment weighting was used to balance baseline covariates, and weighted Cox proportional hazards regression models were used to assess the association between new analgesic therapy and hazard of an emergency department visit after an MVC. RESULTS: Of the 1 454 824 individuals included in the study, 765 464 (52.6%) were new opioid recipients and 689 360 (47.4%) were new NSAID recipients. Most participants were aged 65 years or older (75.2%), and 55.2% were women. Of 194 individuals who had emergency department visits for injuries from an MVC within 14 days of initiating therapy, 98 (50.5%) were opioid recipients (3.41 per 1000 person-years; 95% CI, 2.80-4.15 per 1000 person-years) and 96 (49.5%) were NSAID recipients (3.64 per 1000 person-years; 95% CI, 2.98-4.45 per 1000 person-years). There was no significant difference in the risk of an emergency department visit for MVC injuries between opioid and NSAID recipients (weighted hazard ratio, 0.94; 95% CI, 0.70-1.25). CONCLUSIONS AND RELEVANCE: The findings of this study suggest that the hazard of an emergency department visit for injuries relating to an MVC as a driver is similar between individuals starting prescription opioids and those starting prescription NSAIDs. These results may be useful for patients, clinicians, and caregivers when considering new analgesic therapy. American Medical Association 2021-11-11 /pmc/articles/PMC8586904/ /pubmed/34762109 http://dx.doi.org/10.1001/jamanetworkopen.2021.34248 Text en Copyright 2021 Guan Q et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Guan, Qi
McCormack, Daniel
Juurlink, David N.
Bronskill, Susan E.
Wunsch, Hannah
Gomes, Tara
New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
title New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
title_full New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
title_fullStr New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
title_full_unstemmed New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
title_short New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
title_sort new opioid use and risk of emergency department visits related to motor vehicle collisions in ontario, canada
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586904/
https://www.ncbi.nlm.nih.gov/pubmed/34762109
http://dx.doi.org/10.1001/jamanetworkopen.2021.34248
work_keys_str_mv AT guanqi newopioiduseandriskofemergencydepartmentvisitsrelatedtomotorvehiclecollisionsinontariocanada
AT mccormackdaniel newopioiduseandriskofemergencydepartmentvisitsrelatedtomotorvehiclecollisionsinontariocanada
AT juurlinkdavidn newopioiduseandriskofemergencydepartmentvisitsrelatedtomotorvehiclecollisionsinontariocanada
AT bronskillsusane newopioiduseandriskofemergencydepartmentvisitsrelatedtomotorvehiclecollisionsinontariocanada
AT wunschhannah newopioiduseandriskofemergencydepartmentvisitsrelatedtomotorvehiclecollisionsinontariocanada
AT gomestara newopioiduseandriskofemergencydepartmentvisitsrelatedtomotorvehiclecollisionsinontariocanada